Contreras Jaime 4

4 · ABBOTT LABORATORIES · Filed Apr 29, 2019

Form 4

Period: 2019-04-25

Senior Vice President

Transactions

Exercise/Conversion
Common shares without par value
2019-04-25$59.94/sh+36,716$2,200,757→ 117,438 total
Exercise/Conversion
Common shares without par value
2019-04-26$38.40/sh+80,860$3,105,024→ 115,566 total
Tax Payment
Common shares without par value
2019-04-26$78.11/sh−57,962$4,527,412→ 57,604 total
Exercise/Conversion
Option (right to buy)
2019-04-25−36,716→ 73,430 total
Exercise: $59.94From: 2019-02-16Exp: 2028-02-15→ Common shares (36,716 underlying)
Sale
Common shares without par value
2019-04-25$70.02/sh−12,332$863,487→ 34,706 total
Exercise/Conversion
Option (right to buy)
2019-04-26−80,860→ 0 total
Exercise: $38.40From: 2019-02-19Exp: 2026-02-18→ Common shares (80,860 underlying)
Exercise/Conversion
Common shares without par value
2019-04-25$44.40/sh+46,016$2,043,110→ 80,722 total
Sale
Common shares without par value
2019-04-25$70.00/sh−70,400$4,928,000→ 47,038 total
Exercise/Conversion
Option (right to buy)
2019-04-25−46,016→ 46,016 total
Exercise: $44.40From: 2019-02-17Exp: 2027-02-16→ Common shares (46,016 underlying)

Holdings

Footnotes (6)

[F1]Balance in the Abbott Laboratories Stock Retirement Trust as of April 25, 2019.
[F2]Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.
[F3]The reporting person disclaims beneficial ownership of all securities held by his spouse.
[F4]Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.
[F5]Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
[F6]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Documents

1 file